|
Index of reports
> Cases with Premature Delivery (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Betamethasone (Betamethasone Topical) where reactions include premature delivery. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Betamethasone side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-23
Patient: 19 year old female
Reactions: Pancreatitis Acute, Glycosylated Haemoglobin Increased, Drug Ineffective, Maternal Exposure During Pregnancy, Premature Delivery, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetylsalicylic Acid SRT
Dosage: 75 mg
Folic Acid
Dosage: 5 mg
Betamethasone
Indication: Maternal Therapy To Enhance Foetal Lung Maturity
Insulin
Indication: Diabetes Mellitus
Atorvastatin
Dosage: 40 mg
Indication: Hyperlipidaemia
Fenofibrate
Dosage: 200 mg
Indication: Hypertriglyceridaemia
Insulin
Dosage: 300 u per day
Possible Betamethasone side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-22
Patient: 19 year old female
Reactions: Pancreatitis Acute, Glycosylated Haemoglobin Increased, Premature Delivery, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin
Dosage: daily dose 40 mg
Indication: Hypertriglyceridaemia
Insulin
Dosage: 20 units/h
Betamethasone
Indication: Maternal Therapy To Enhance Foetal Lung Maturity
Folic Acid
Dosage: daily dose 5 mg
Aspirin
Dosage: daily dose 75 mg
Insulin
Indication: Diabetes Mellitus
Insulin
Dosage: 5 u/kg per day
Fenofibrate
Dosage: 200 mg, unk
Indication: Hypertriglyceridaemia
Possible Betamethasone side effects in 19 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-17
Patient: 19 year old female
Reactions: Pancreatitis Acute, Glycosylated Haemoglobin Increased, Drug Ineffective, Maternal Exposure During Pregnancy, Premature Delivery, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aspirin
Dosage: 75 mg
Atorvastatin
Dosage: 40 mg
Indication: Hyperlipidaemia
Insulin
Indication: Diabetes Mellitus
Betamethasone
Indication: Maternal Therapy To Enhance Foetal Lung Maturity
Insulin
Dosage: 300 u per day
Fenofibrate
Dosage: 200 mg
Indication: Hypertriglyceridaemia
Folic Acid
Dosage: 5 mg
Possible Betamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-06
Patient: female
Reactions: Emotional Distress, Chorioamnionitis, Bipolar Disorder, Maternal Exposure During Pregnancy, Premature Delivery
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lexapro
Administration route: Oral
Indication: Bipolar Disorder
Zithromax
Indication: Product Used FOR Unknown Indication
Prometrium
Administration route: Oral
Indication: Pregnancy
Topamax
Administration route: Oral
Indication: Anxiety
Start date: 2001-01-01
End date: 2007-01-01
Lithium Carbonate
Administration route: Oral
Indication: Bipolar Disorder
Betamethasone
Indication: Product Used FOR Unknown Indication
Clindamycin
Indication: Bacterial Infection
Topamax
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2001-01-01
End date: 2007-01-01
Nifedipine
Indication: Product Used FOR Unknown Indication
Ampicillin
Indication: Product Used FOR Unknown Indication
Terbutaline
Administration route: Oral
Indication: Premature Labour
Possible Betamethasone side effects in 32 year old female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-05
Patient: 32 year old female
Reactions: Caesarean Section, Cardiac Failure, Ventricular Tachycardia, Maternal Exposure During Pregnancy, Condition Aggravated, Atrioventricular Block, Premature Delivery, Atrioventricular Block Second Degree
Drug(s) suspected as cause:
Metoprolol Tartrate
Dosage: 50-75 mg/day
Betamethasone
Furosemide
Dosage: 40 mg
Digitalis
Dosage: 0.1 mg/day
Spironolactone
Dosage: 12.5 mg/day
Isosorbide Mononitrate
Dosage: 20 mg, bid
Dihydralazine
Dosage: 25 mg, tid
Enalapril Maleate
Dosage: 5 mg, bid
Enalapril Maleate
Dosage: 2.5 mg, qd
Possible Betamethasone side effects in 32 year old female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-05
Patient: 32 year old female
Reactions: Cardiac Failure, Maternal Exposure During Pregnancy, Ventricular Tachycardia, Atrioventricular Block, Premature Delivery
Drug(s) suspected as cause:
Isosorbide Mononitrate
Dosage: 20 mg, bid
Dihydralazine
Dosage: 25 mg, tid
Betamethasone
Enalapril Maleate
Dosage: 2.5 mg, qd
Spironolactone
Dosage: 12.5 mg/day
Metoprolol Tartrate
Dosage: 50-75 mg/day
Enalapril Maleate
Dosage: 5 mg, bid
Furosemide
Dosage: 40 mg
Digitalis
Dosage: 0.1 mg/day
Possible Betamethasone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25
Patient: female
Reactions: Emotional Distress, Chorioamnionitis, Bipolar Disorder, Maternal Exposure During Pregnancy, Premature Delivery
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Topamax
Administration route: Oral
Indication: Anxiety
Start date: 2001-01-01
End date: 2007-01-01
Terbutaline
Administration route: Oral
Indication: Premature Labour
Lexapro
Administration route: Oral
Indication: Bipolar Disorder
Topamax
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2001-01-01
End date: 2007-01-01
Lithium Carbonate
Administration route: Oral
Indication: Bipolar Disorder
Nifedipine
Indication: Product Used FOR Unknown Indication
Prometrium
Administration route: Oral
Indication: Pregnancy
Ampicillin
Indication: Product Used FOR Unknown Indication
Betamethasone
Indication: Product Used FOR Unknown Indication
Clindamycin
Indication: Bacterial Infection
Zithromax
Indication: Product Used FOR Unknown Indication
Possible Betamethasone side effects in female
Reported by a consumer/non-health professional from Japan on 2012-04-20
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Blood Pressure Increased, Maternal Exposure During Pregnancy, Hypertensive Nephropathy, Premature Delivery
Drug(s) suspected as cause:
Sugammadex
Start date: 2011-04-16
End date: 2011-04-16
Nicardipine HCL
Dosage: 120 mg, (5 ml/hr, 5 mg/hr)
Indication: Blood Pressure Increased
Start date: 2011-04-15
End date: 2011-04-18
Rocuronium Bromide
Indication: Anaesthesia
Start date: 2011-04-16
End date: 2011-04-16
Sevoflurane
Start date: 2011-04-16
End date: 2011-04-16
Betamethasone
Neupogen
Propofol
Indication: Anaesthesia
Start date: 2011-04-16
End date: 2011-04-16
Fentanyl-100
Indication: Anaesthesia
Start date: 2011-04-16
End date: 2011-04-16
Other drugs received by patient: Midazolam; Nitrous Oxide
Possible Betamethasone side effects in female
Reported by a lawyer from United States on 2012-04-12
Patient: female
Reactions: Emotional Distress, Chorioamnionitis, Maternal Exposure During Pregnancy, Premature Delivery
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Betamethasone
Indication: Product Used FOR Unknown Indication
Topamax
Administration route: Oral
Indication: Anxiety
Start date: 2001-01-01
End date: 2007-01-01
Terbutaline
Administration route: Oral
Indication: Premature Labour
Prometrium
Administration route: Oral
Indication: Pregnancy
Topamax
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2001-01-01
End date: 2007-01-01
Lithium Carbonate
Administration route: Oral
Indication: Bipolar Disorder
Clindamycin
Indication: Bacterial Infection
Ampicillin
Indication: Product Used FOR Unknown Indication
Lexapro
Administration route: Oral
Indication: Bipolar Disorder
Nifedipine
Indication: Product Used FOR Unknown Indication
Zithromax
Indication: Product Used FOR Unknown Indication
Possible Betamethasone side effects in female
Reported by a lawyer from United States on 2012-03-22
Patient: female
Reactions: Emotional Distress, Chorioamnionitis, Maternal Exposure During Pregnancy, Premature Delivery
Drug(s) suspected as cause:
Prometrium
Administration route: Oral
Indication: Pregnancy
Zithromax
Indication: Product Used FOR Unknown Indication
Clindamycin
Indication: Bacterial Infection
Nifedipine
Indication: Product Used FOR Unknown Indication
Topamax
Administration route: Oral
Indication: Anxiety
Start date: 2001-01-01
End date: 2007-01-01
Lithium Carbonate
Administration route: Oral
Indication: Bipolar Disorder
Betamethasone
Indication: Product Used FOR Unknown Indication
Topamax
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2001-01-01
End date: 2007-01-01
Terbutaline
Administration route: Oral
Indication: Premature Labour
Lexapro
Administration route: Oral
Indication: Bipolar Disorder
Ampicillin
Indication: Product Used FOR Unknown Indication
Possible Betamethasone side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-15
Patient: 25 year old female, weighing 52.0 kg (114.4 pounds)
Reactions: Maternal Exposure During Pregnancy, Premature Delivery
Drug(s) suspected as cause:
Nicardipine HCL
Indication: Blood Pressure Increased
Betamethasone
Rocuronium Bromide
Indication: Anaesthesia
Propofol
Indication: Anaesthesia
Neupogen
Fentanyl
Indication: Anaesthesia
Sugammadex
Sevoflurane
Other drugs received by patient: Nitrous Oxide; Midazolam
Possible Betamethasone side effects in 32 year old female
Reported by a physician from Germany on 2012-02-22
Patient: 32 year old female
Reactions: Premature Rupture of Membranes, Premature Delivery, Pregnancy
Drug(s) suspected as cause:
Marcumar
Dosage: 0-4 gestational week
Administration route: Oral
Indication: Thrombosis Prophylaxis
End date: 2010-01-01
Enoxaparin Sodium
Dosage: daily dose:40mg
Indication: Thrombosis Prophylaxis
Start date: 2010-01-01
Folasaure
Dosage: 4-12 gestational week
Administration route: Oral
Indication: Prophylaxis of Neural Tube Defect
Start date: 2010-01-01
End date: 2010-01-01
Betamethasone
Dosage: 32.1-32.2 gestational week
Indication: Maternal Therapy To Enhance Foetal Lung Maturity
Start date: 2011-05-08
End date: 2011-05-09
Keppra
Administration route: Oral
Indication: Epilepsy
|
